http://www.medicalnewstoday.com/articles/129828.php
--Frank
Phase-III Laquinimod trial completed patient enrollment
Phase-III Laquinimod trial completed patient enrollment
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.